Concepedia

N. Schmidely

NS

6

Publications

623

Citations

6

H-Index

2005

Active since

Affiliations

Bristol-Myers Squibb (France)(Current)

Hôpital Cochin

University of Liège

Sorbonne Université

Inserm

N. Schmidely is an author at Bristol-Myers Squibb (France) specializing in public health, medicine, and patient-reported outcomes.

Top concepts

Publications per year

2005–2022

6

Publications

6

Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy

Mark C. Genovese, M. Schiff, Michael E. Luggen et al. · Annals of the Rheumatic Diseases · 2007 · 266 citations

Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study

Philip G. Conaghan, Maria Antonietta D’Agostino, Manuela Le Bars et al. · Annals of the Rheumatic Diseases · 2009 · 190 citations · Full text

Clinically Relevant Genotype Interpretation of Resistance to Didanosine

Anne‐Geneviève Marcelin, Philippe Flandre, Juliette Pavie et al. · Antimicrobial Agents and Chemotherapy · 2005 · 71 citations · Full text

, , +16

EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 2: Exploring decision rules for clinical utility

Philip G. Conaghan, Maria Antonietta D’Agostino, Philippe Ravaud et al. · Annals of the Rheumatic Diseases · 2005 · 62 citations · Full text

Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data

Maxime Dougados, N. Schmidely, Manuela Le Bars et al. · Annals of the Rheumatic Diseases · 2008 · 21 citations · Full text

Rows per page

1–5 of 6